Lymphoma: all 5,624 studies
Page 50 of 57. Open to participants first (824), then studies with results posted, then the rest; newest registration first within each.
- Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/LymphomaCompletedNCT00214370Not applicable
- A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's LymphomaCompletedNCT00211276Phase 2
- Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT00211198Phase 4
- VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic TherapyTerminatedNCT00210392Phase 2
- Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's LymphomaCompletedNCT00210379Phase 2
- Salvage Therapy With Idarubicin in Relapsing CNS LymphomaTerminatedNCT00210366Phase 2
- VELCADE in MALT Lymphoma Pretreated With Prior Systemic TherapyCompletedNCT00210327Phase 2
- Phase II Trial of Combined Modality Treatment in Primary Central Nervous System LymphomaCompletedNCT00210314Phase 2
- Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCLStatus unknownNCT00209209Phase 3
- Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's DiseaseTerminatedNCT00209014Phase 2
- Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's LymphomaCompletedNCT00204659Phase 2
- Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaCompletedNCT00201682Phase 1/2
- A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00201669Phase 2
- Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALTomaCompletedNCT00201422Not applicable
- A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface AntigenCompletedNCT00201318Phase 2
- Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in AdultsCompletedNCT00199082Phase 4
- Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade LymphomaCompletedNCT00199043Phase 3
- Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampathCompletedNCT00199030Phase 2
- German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in AdultsCompletedNCT00199017Phase 4
- Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic LymphomaStatus unknownNCT00195871Phase 2
- Idarubicin Based Combined Modality Therapy in Primary CNS LymphomaCompletedNCT00193973Phase 2
- Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT00193518Phase 2
- Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell LymphomaCompletedNCT00193505Phase 2
- Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00193466Phase 2
- Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's LymphomaCompletedNCT00193440Phase 2
- High Dose CHOP in LymphomaCompletedNCT00192764Phase 2
- Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's LymphomaCompletedNCT00188929Phase 2
- Ultrasound Biomicroscopy - ApoptosisCompletedNCT00188370Phase 2
- Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHLCompletedNCT00187161Phase 2
- Treatment for Patients With Stage III or IV Non-Hodgkin LymphomaCompletedNCT00187122Not applicable
- Large Cell Lymphoma Pilot Study IIICompletedNCT00187070Not applicable
- 90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHLCompletedNCT00186589Phase 1
- High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's LymphomaCompletedNCT00186394Phase 2
- Enrichment & Purging of Stem Cells in Non-Hodgkin's LymphomaCompletedNCT00186355Not applicable
- Allo BMT in Advanced Leukemia or High Grade LymphomaCompletedNCT00186290Not applicable
- Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line ChemotherapyCompletedNCT00185393Phase 3
- Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00184080Phase 2
- Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell LymphomaTerminatedNCT00183989Phase 2
- Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's LymphomasTerminatedNCT00183976Phase 2
- Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to ChemotherapyTerminatedNCT00183950Phase 1/2
- Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's LymphomaCompletedNCT00182650Phase 1
- Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALLTerminatedNCT00180895Phase 2
- LMBA02 Protocol for Patients With a Burkitt LymphomaStatus unknownNCT00180882Phase 3
- Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular LymphomaCompletedNCT00177554Phase 2
- In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT00177190
- Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative DiseaseTerminatedNCT00176475Phase 1
- Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised StudyStatus unknownNCT00169598Not applicable
- Association of Velcade to R-CHOP in the Treatment of B Cell LymphomaCompletedNCT00169468Phase 2
- Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's LymphomaCompletedNCT00169208Phase 2
- Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell LymphomaCompletedNCT00169195Phase 2
- Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell LymphomaTerminatedNCT00169169Phase 3
- A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic LymphomaCompletedNCT00169156Phase 2
- Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell LymphomaCompletedNCT00169143Phase 2
- ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell LymphomaCompletedNCT00169130Phase 2/3
- Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)CompletedNCT00168740Phase 3
- Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's LymphomaCompletedNCT00168727Phase 4
- Efficacy Study of Outpatient Therapy for LymphomaCompletedNCT00163761Phase 2
- Efficacy and Treatment Related Toxicity Study of a New Regimen for LymphomaCompletedNCT00163748Phase 2
- Prevention of CHOP-induced Chronic CardiotoxicityCompletedNCT00162955Phase 4
- Treatment of Mature B-cell Lymphoma/LeukaemiaCompletedNCT00162656Phase 3
- Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell LymphomaCompletedNCT00161590Phase 1
- LAMPP Trial for Peripheral and Cutaneous T-Cell LymphomaTerminatedNCT00161239Not applicable
- Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: RadiationStatus unknownNCT00154440Phase 3
- Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)CompletedNCT00153530Phase 4
- Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and LymphomasCompletedNCT00152126Not applicable
- Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's LymphomaTerminatedNCT00148018Phase 2
- Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00147953Phase 2
- Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's LymphomaCompletedNCT00147875Phase 1/2
- Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)CompletedNCT00147121Phase 2/3
- Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the BloodCompletedNCT00146055Phase 2
- A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)CompletedNCT00145002Phase 3
- ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell LymphomaCompletedNCT00144807Phase 2
- R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell LymphomaCompletedNCT00144755Phase 3
- HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's LymphomaCompletedNCT00144092Phase 2
- Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the BloodTerminatedNCT00143884Phase 2
- Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's LymphomaCompletedNCT00143871Phase 2
- Stem Cell Transplantation as Immunotherapy for Hematologic MalignanciesCompletedNCT00143559Phase 2
- Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00143065Phase 2
- Phase II Study of Campath-1H Antibody to Treat Waldenstrom's MacroglobulinemiaCompletedNCT00142181Phase 2
- Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's LymphomaTerminatedNCT00141700Phase 2
- ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell LymphomaTerminatedNCT00140660Phase 3
- ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1CompletedNCT00140595Phase 3
- Primary Rituximab and MaintenanceCompletedNCT00140582Phase 3
- Randomized Study for Patients With Follicular Lymphoma Needing TreatmentCompletedNCT00140569Phase 3
- Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to RituximabCompletedNCT00139841Phase 3
- Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00138164Phase 2
- Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell LymphomaCompletedNCT00138086Phase 2
- R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell LymphomaCompletedNCT00137995Phase 3
- A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell LymphomaTerminatedNCT00136591Phase 2
- Study of Bortezomib Combined With ACVBP in Peripheral T-cell LymphomaCompletedNCT00136565Phase 2
- Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor BurdenCompletedNCT00136552Phase 3
- Amifostine for Head and Neck Irradiation in LymphomaCompletedNCT00136474Phase 2
- R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell LymphomaTerminatedNCT00135499Phase 3
- Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)TerminatedNCT00133302Phase 3
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisCompletedNCT00132015Phase 2
- Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's LymphomaCompletedNCT00129090Phase 3
- A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030)CompletedNCT00127140Phase 1
- BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's LymphomaCompletedNCT00126646Phase 1
- Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic CancerCompletedNCT00126477
- Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaTerminatedNCT00126243Phase 2